Serial Screening for COVID-19 in Asymptomatic Patients Receiving Anticancer Therapy in the United Arab Emirates
- 1 January 2021
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 7 (1) , 129-131
Abstract
Patients with cancer, especially those receiving anticancer therapy, are at risk amidst the coronavirus disease 2019 (COVID-19) pandemic.1-3 Given the frequency of asymptomatic COVID-19,2,4,5 and presymptomatic transmission,5 symptom-based screening may inadequately triage patients to safely resume anticancer therapy.2,6Keywords
This publication has 6 references indexed in Scilit:
- Screening for COVID-19 in Asymptomatic Patients With Cancer in a Hospital in the United Arab EmiratesJAMA Oncology, 2020
- Testing recommendation for COVID-19 (SARS-CoV-2) in patients planned for surgery - continuing the service and ‘suppressing’ the pandemicBritish Journal of Oral and Maxillofacial Surgery, 2020
- Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing FacilityNew England Journal of Medicine, 2020
- COVID-19: PCR screening of asymptomatic health-care workers at London hospitalThe Lancet, 2020
- A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative GroupThe Oncologist, 2020
- Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, ChinaAnnals of Oncology, 2020